Who owns the SERCA PHARMACEUTICALS trademark?

The SERCA PHARMACEUTICALS trademark is owned by SERCA PHARMACEUTICALS AS.

What is the serial number for SERCA PHARMACEUTICALS?

The USPTO serial number for SERCA PHARMACEUTICALS is 79333099.

What is the registration number for SERCA PHARMACEUTICALS?

SERCA PHARMACEUTICALS is registered under USPTO registration number 7215194.

SER

USPTO Trademark Record

REGISTERED

SERCA PHARMACEUTICALS

Q: What class is the SERCA PHARMACEUTICALS trademark registered in?

The SERCA PHARMACEUTICALS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services), Class 040 (Treatment & processing of materials), Class 042 (Scientific, technology & SaaS services).

SN 79333099·Reg 7215194·Filed Dec 20, 2021

Owner SERCA PHARMACEUTICALS AS

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Advertising; business management, organization and administration; office functions.; Treatment of materials; recycling of waste and trash; air purification and treatment of water; printing services; food and drink preservation.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

SERCA PHARMACEUTICALS (Serial No. 79333099), Registration No. 7215194, is a registered US trademark filed on Dec 20, 2021 by SERCA PHARMACEUTICALS AS. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services), Class 040 (Treatment & processing of materials), Class 042 (Scientific, technology & SaaS services).

early section 8: November 14, 2029

Mark Intelligence

SERCA PHARMACEUTICALS (Reg. #7215194) is a registered US trademark that has been protecting its owner, SERCA PHARMACEUTICALS AS, since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services), Class 040 (Treatment & processing of materials) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Dec 20, 2021

SERIAL

79333099

REG#

7215194

REGISTERED

Nov 14, 2023

Owner

Applicant

SERCA PHARMACEUTICALS AS

Entity

Not Provided

Address

Gaustadalléen 21, N-0349 Oslo

Country

Attorney

NameSusan Stabe

Law firm

Susan Stabe Kutak Rock LLP

Docket

81117-2

Address

2405 Grand Boulevard, Suite 600, Kansas City, MO 64108, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateDec 20, 2021

Serial Number79333099

Registration No.7215194

Registration DateNov 14, 2023

Status DateNov 14, 2023

Published for OppositionAug 29, 2023

Mark TypeDesign with words

Attorney Docket81117-2

Status DescriptionLive and registered

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 3× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

Advertising; business management, organization and administration; office functions.

Class 040Treatment & processing of materials

US codes: 100, 103, 106

Treatment of materials; recycling of waste and trash; air purification and treatment of water; printing services; food and drink preservation.

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

46 events

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jul 17, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jul 17, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Jul 17, 2025

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 17, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

NEW REPRESENTATIVE AT IB RECEIVED

Feb 14, 2025

NEW REPRESENTATIVE AT IB RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 24, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 24, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Jan 24, 2025

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 24, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

NEW REPRESENTATIVE AT IB RECEIVED

Nov 08, 2024

NEW REPRESENTATIVE AT IB RECEIVED

FINAL DECISION TRANSACTION PROCESSED BY IB

Mar 04, 2024

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Feb 14, 2024

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

FINAL DISPOSITION PROCESSED

Feb 14, 2024

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Feb 14, 2024

FINAL DISPOSITION NOTICE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Nov 14, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Nov 14, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Aug 29, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 29, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Aug 28, 2023

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 09, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Aug 09, 2023

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Aug 09, 2023

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 27, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 06, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 06, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 06, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

PRIORITY ACTION WRITTEN

Apr 13, 2023

PRIORITY ACTION WRITTEN

PRIORITY ACTION E-MAILED

Apr 13, 2023

PRIORITY ACTION E-MAILED

NOTIFICATION OF PRIORITY ACTION E-MAILED

Apr 13, 2023

NOTIFICATION OF PRIORITY ACTION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 15, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 15, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 15, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Dec 28, 2022

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Dec 07, 2022

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Dec 07, 2022

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

ATTORNEY REVIEW COMPLETED

Nov 17, 2022

ATTORNEY REVIEW COMPLETED

CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED

Oct 26, 2022

CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED

CHANGE OF NAME/ADDRESS REC'D FROM IB

Oct 07, 2022

CHANGE OF NAME/ADDRESS REC'D FROM IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Sep 27, 2022

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

ASSIGNED TO EXAMINER

Sep 26, 2022

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Sep 26, 2022

NON-FINAL ACTION WRITTEN

CORRECTION TRANSACTION RECEIVED FROM IB

Jul 23, 2022

CORRECTION TRANSACTION RECEIVED FROM IB

NEW REPRESENTATIVE AT IB RECEIVED

May 28, 2022

NEW REPRESENTATIVE AT IB RECEIVED

APPLICATION FILING RECEIPT MAILED

Feb 19, 2022

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 15, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Feb 10, 2022

SN ASSIGNED FOR SECT 66A APPL FROM IB

SERCA PHARMACEUTICALS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Susan Stabe

Resources

Company